XTL Biopharmaceuticals Ltd. (XTLB)
0.7628
0.00 (0.00%)
USD |
NASDAQ |
Feb 27, 16:00
0.7101
-0.05
(-6.91%)
After-Hours: 20:00
XTL Biopharmaceuticals Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Compugen Ltd. | 86.16M |
| Pluri, Inc. | 63.51M |
| BioLineRx Ltd. | -1.520M |
| Can-Fite BioPharma Ltd. | -- |
| Evogene Ltd. | 10.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.257M |
| Revenue (Quarterly) | 0.2913M |
| Total Expenses (Quarterly) | 0.5483M |
| EPS Diluted (Quarterly) | -0.0292 |